APL Healthcare Limited Potassium Export Data — India (DGFT 2022–2026)

Name: APL Healthcare Limited Potassium Export Records India — #12 Exporter, 81 Shipments, $4.0M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-04-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Potassium

India Pharmaceutical Trade Intelligence

$642.2M877 Suppliers177 CountriesHS 30041090

ExportsIndia → UNITED STATES50.4%India → HONG KONG6.0%

ImportsCHINA → India$11.7B GERMANY → India$530.9M

#1 Buyer: EVERSANA LIFE

APL Healthcare Limited — Potassium Exporter #12 | $4.0M Trade Value | TransData Nexus | TransData Nexus

APL Healthcare Limited — Potassium Exporter Profile

Indian Pharmaceutical Exporter · #12 for Potassium · $4.0M export value · DGFT Verified

APL Healthcare Limited is the #12 Indian exporter of Potassium with $4.0M in export value and 81 verified shipments. APL Healthcare Limited holds a 0.6% market share in Potassium exports across 1 countries. The company exports 17 pharmaceutical products worth $27.3M across 11 therapeutic categories.

APL Healthcare Limited — Potassium Export Profile: Buyers & Destinations

APL Healthcare Limited Potassium export treemap — buyers and destination countries | TransData Nexus

Where Does India Export Potassium?

Country	Value	Shipments	Share
UNITED STATES	$134.0M	2,680	50.6%
PHILIPPINES	$29.3M	707	11.0%
NIGERIA	$16.8M	500	6.3%
SRI LANKA	$13.9M	279

Who Are the Top Buyers of Potassium from India?

Buyer	Country	Value	Orders
EVERSANA LIFE SCIENCE SERVICES	UNITED STATES	$12.1M	241
AUROLOGISTICS LLC, (AUROBINDO PHARM	UNITED STATES	$11.7M	234
AUROBINDO PHARMA USA INC	UNITED STATES	$7.7M	154
GRANULES PHARMACEUTICALS INC	UNITED STATES	$5.5M	109
GRANULES PHARMACEUTICALS, INC.	UNITED STATES	$5.0M	100
AUROBINDO PHARMA USA., INC,	UNITED STATES	$4.8M	95
NELPA LIFESCIENCES INC	PHILIPPINES	$2.3M	45
MYLAN PHARMACEUTICALS INC,	UNITED STATES	$1.9M	39
RELIABLE HEALTHCARE LOGISTICS LLC	UNITED STATES	$1.4M	27
DCH AURIGA(HONG KONG)LTD	HONG KONG	$150.0K	3

India's Potassium is purchased by 2,474 buyers worldwide. The top buyer is EVERSANA LIFE SCIENCE SERVICES (UNITED STATES), followed by AUROLOGISTICS LLC, (AUROBINDO PHARM and AUROBINDO PHARMA USA INC.

How Does APL Healthcare Limited Compare to Nearest Potassium Exporters?

Exporters ranked immediately above and below #12 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
15	IPCA LABORATORIES LIMITED	$5.3M	107	15	$50.0K
2	MYLAN LABORATORIES LIMITED	$4.5M	91	3	$50.0K
12	APL HEALTHCARE LIMITED ★	$4.0M	81	1	$50.0K
13	MEDOPHARM	$3.4M	68	14	$50.0K
10	ZYDUS TAKEDA HEALTHCARE PRIVATE LIMITED	$400.0K	8	1	$50.0K

APL Healthcare Limited ranks #12 among 877 Indian Potassium exporters. Average shipment value of $50.0K compared to the market average of $257.6K. The closest competitors by value are IPCA LABORATORIES LIMITED and MYLAN LABORATORIES LIMITED.

Which Indian Ports Ship Potassium Exports?

Port	Shipments	% Share
NHAVA SHEVA SEA (INNSA1)	1,108	7.4%
SAHAR AIR	916	6.1%
SAHAR AIR CARGO ACC (INBOM4)	911	6.1%
DELHI AIR CARGO ACC (INDEL4)	791	5.3%
HYDERABAD ICD (INSNF6)	767	5.1%
DELHI AIR	715	4.8%
JNPT/ NHAVA SHEVA SEA	645	4.3%
HYDERABAD ICD	644	4.3%

Geopolitical & Trade Policy Impact on APL Healthcare Limited's Potassium Exports

The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like APL Healthcare. The Israel-Iran conflict has disrupted Red Sea shipping routes, leading to increased freight costs and extended transit times. These disruptions are particularly impactful for time-sensitive pharmaceutical shipments, necessitating strategic adjustments in logistics and inventory management. (pharmaceuticalcommerce.com)

Conversely, US-China trade tensions have prompted the United States to seek alternative pharmaceutical suppliers, potentially benefiting Indian exporters. However, the looming threat of US tariffs on pharmaceutical imports adds a layer of uncertainty. In March 2025, Indian pharma exports to the US surged by 74% amid tariff concerns, indicating proactive measures by exporters to mitigate potential impacts. (business-standard.com)

The recent India-European Union Free Trade Agreement, signed in January 2026, is poised to eliminate tariffs on pharmaceuticals, enhancing market access for Indian exporters. This development offers APL Healthcare an opportunity to strengthen its presence in the European market, provided it aligns with EU regulatory standards. (en.wikipedia.org)

APL Healthcare Limited — Regulatory Compliance & Quality Standards

Compliance with international regulatory standards is paramount for Indian pharmaceutical exporters. India has made significant strides in this area, with 752 FDA-approved, 2,050 WHO GMP-certified, and 286 EDQM-approved manufacturing sites as of 2024. (business-standard.com) This robust compliance framework enhances the credibility of Indian pharmaceuticals in global markets.

For APL Healthcare, maintaining and enhancing compliance with FDA, WHO, and EU GMP standards is crucial. Adherence to evolving quality requirements not only ensures market access but also builds trust with international partners. Continuous investment in quality assurance and regulatory affairs will be essential to navigate the complex global pharmaceutical landscape.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Potassium shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: APL Healthcare Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 177+ countries, 2,474+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Potassium

Potassium

APL Healthcare Limited — Potassium Exporter Profile

APL Healthcare Limited — Potassium Export Profile: Buyers & Destinations

Where Does India Export Potassium?

Who Are the Top Buyers of Potassium from India?

What Is India's Total Potassium Export Value and How Much Does APL Healthcare Limited Contribute?

What Is the Average Shipment Value for APL Healthcare Limited's Potassium Exports?

How Does APL Healthcare Limited Compare to Other Indian Potassium Exporters?

Regulatory Requirements: Exporting Potassium to Key Markets

United States — FDA

Nigeria — NAFDAC

How Does APL Healthcare Limited Compare to Nearest Potassium Exporters?

Which Indian Ports Ship Potassium Exports?

Geopolitical & Trade Policy Impact on APL Healthcare Limited's Potassium Exports

APL Healthcare Limited — Regulatory Compliance & Quality Standards

About APL Healthcare Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Potassium Export Data from APL Healthcare Limited

Potassium Stats

Company Overview

Top Products by APL Healthcare Limited

Related Analysis

Need Detailed Export Data?

Data Source